pSI-Target-AID-NG Citations (5)
Originally described in: Engineered CRISPR-Cas9 nuclease with expanded targeting space.Nishimasu H, Shi X, Ishiguro S, Gao L, Hirano S, Okazaki S, Noda T, Abudayyeh OO, Gootenberg JS, Mori H, Oura S, Holmes B, Tanaka M, Seki M, Hirano H, Aburatani H, Ishitani R, Ikawa M, Yachie N, Zhang F, Nureki O Science. 2018 Aug 30. pii: science.aas9129. doi: 10.1126/science.aas9129. PubMed Journal
Articles Citing pSI-Target-AID-NG
| Articles |
|---|
| CRISPR Base Editing in Induced Pluripotent Stem Cells. Chang YJ, Xu CL, Cui X, Bassuk AG, Mahajan VB, Tsai YT, Tsang SH. Methods Mol Biol. 2019 Jun 28. doi: 10.1007/7651_2019_243. PubMed |
CRISPR DNA base editors with reduced RNA off-target and self-editing activities.
Grunewald J, Zhou R, Iyer S, Lareau CA, Garcia SP, Aryee MJ, Joung JK.
Nat Biotechnol. 2019 Sep 2. pii: 10.1038/s41587-019-0236-6. doi: 10.1038/s41587-019-0236-6.
PubMed
Associated Plasmids |
Modeling Niemann-Pick disease type C in a human haploid cell line allows for patient variant characterization and clinical interpretation.
Erwood S, Brewer RA, Bily TMI, Maino E, Zhou L, Cohn RD, Ivakine EA.
Genome Res. 2019 Dec;29(12):2010-2019. doi: 10.1101/gr.250720.119. Epub 2019 Nov 21.
PubMed
Associated Plasmids |
| Cytosine Base Editor (hA3A-BE3-NG)-Mediated Multiple Gene Editing for Pyramid Breeding in Pigs. Wang Y, Bi D, Qin G, Song R, Yao J, Cao C, Zheng Q, Hou N, Wang Y, Zhao J. Front Genet. 2020 Nov 16;11:592623. doi: 10.3389/fgene.2020.592623. eCollection 2020. PubMed |
| Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity. Magdy T, Jouni M, Kuo HH, Weddle CJ, Lyra-Leite D, Fonoudi H, Romero-Tejeda M, Gharib M, Javed H, Fajardo G, Ross CJD, Carleton BC, Bernstein D, Burridge PW. Circulation. 2022 Jan 25;145(4):279-294. doi: 10.1161/CIRCULATIONAHA.121.055801. Epub 2021 Dec 7. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.